Cerevel Therapeutics (CERE): Stock Price

Graphic logo of Cerevel Corp (CERE)

Cerevel Therapeutics (CERE) develops targeted medications to combat Parkinson's, Alzheimer's, and schizophrenia while minimizing adverse bodily reactions. The business relies on partnerships with scientific centers, which enabled the integration of test results into a global player's structure via M&A. The market price action of the securities, shown below, is recorded at 44.95. Asset stability is guaranteed by operations within the protected US jurisdiction, remaining outside of trade conflicts.

Price Performance Chart: Cerevel Corp (CERE) for 07/04/2022 - 08/10/2024

Cerevel (CERE) - metric breakdowns and financial figures

Analysis of all company metrics:cerevel.com CERE
Signature product of Cerevel Therapeutics Inc

The closing price records the final market value of the share for the trading day, filtering out short-term noise and reflecting the actual investor consensus regarding the business valuation. Analyzing the market price trend reveals how diversifying development in the fields of schizophrenia and Parkinson's disease reduces specific neurobiology risks, directly impacting the capitalization stability of Cerevel Therapeutics (CERE).

Analysis of competing companies

Stock Price BIIB|Neurocrine Biosciences, Inc. - Share Price|Stock Price RGC (Regencell Bioscience Ltd)|AXSM: Share Price|ACADIA Corp - Stock Price|XENE (Xenon Pharmaceuticals) - Share Price|VKTX (Viking Pharma) - Stock Quotes|Share Price SUPN|Price Chart Catalyst Pharmaceuticals|Share Price DNLI (Denali Therapeutics Inc)|Stock Price HRMY|BHVN - Market Price|amylyx.com - Stock Quotes|Stock Price Trevi Therapeutics Inc TRVI|PRAX - Price Chart|Price Performance Chart AVXL (Anavex Life Sciences Corp)|CeriBell Inc (CBLL) - Price Chart|Market Price Prothena Corp (PRTA)|ALEC (Alector Therapeutics) - Stock Price|Stock Price Annexon Biosciences|Price Chart Omeros Corp (OMER)|NGNE - Market Price|AC Immune - Stock Quotes|Voyager Therapeutics (VYGR) - Market Price|NMRA - Price Chart|SCLX: Price Chart|TVGN: Stock Price|Alpha Cognition (ACOG) - Stock Price|Stock Quotes CGTX|Stock Price Inhibikase Therapeutics|Stock Price SAVA|Market Chart Assertio Holdings|Stock Price COYA (Coya Therapeutics)|VTGN: Share Price|OVID - Price Chart|Price Performance Chart ABOS (Acumen Pharmaceuticals)|CRVO: Stock Price|ATHE: Price|CLNN (clene.com) - Stock Price|pepgen.com (PEPG) - Market Chart|Price Chart Jupiter Neurosciences Inc (JUNS)|RLMD (Relmada Therapeutics) - Price Performance Chart|Stock Price ANVS (Annovis Bio Inc)|gracetx.com (GRCE) - Market Price|AIFF - Price Chart|anewmeds.com (KLTO) - Stock Quotes|NeuroSense Therapeutics, Ltd. (NRSN) - Price Chart|Market Price Reviva Pharmaceuticals Holdings, Inc. (RVPH)|Price Chart MetaVia|Share Price NRXS (NeurAxis Inc.)|Stock Price HSDT|PASG: Quote Chart|Neuphoria Therapeutics, Inc. - Stock Quotes|NERV: Share Price|athira.com - Stock Price|ADXN - Stock Price|ALZN: Stock Price|CYCN - Market Chart|PTIX (Protagenic Therapeutics, Inc.) - Stock Price|pasitheaclinics.com (KTTA) - Market Chart|Price Chart Cortigent Inc (CRGT)|Avenue Therapeutics, Inc. - Share Price|Price Chart Brainstorm Cell Therapeutics, Inc. BCLI|CARA - Stock Quotes|chromocell.com - Stock Price|Market Price Eliem Therapeutics, Inc.|ITCI: Stock Price|LBPH - Market Chart|Price Chart Marinus Pharmaceuticals|NKGN: Price Performance Chart|Price Chart NeuroBo Pharmaceuticals Inc (NRBO)|Sage Therapeutics, Inc. - Share Price|Synaptogenix, Inc - Stock Quotes|Stock Price Trevena, Inc TRVN|Vigil Neuroscience Inc. - Stock Price|Market Price Anew Medical